Understanding Chronic Lymphocytic Leukemia (CLL) Treatment Options

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. Whereas there’s currently no cure, numerous effective treatments are available to manage the condition and improve quality of life. Treatment strategies for CLL are highly individualized, depending on the stage of the disease, its rate of progression, and the patient’s overall health. This article provides an overview of the common treatment approaches for CLL, from watchful waiting to more aggressive therapies.

Watchful Waiting: A Proactive Approach to Early-Stage CLL

For many individuals newly diagnosed with early-stage CLL that isn’t causing symptoms, or is only causing mild symptoms, immediate treatment isn’t always necessary. This approach, known as watchful waiting (also referred to as observation or active surveillance), involves closely monitoring the disease’s progression without initiating treatment. Research has demonstrated that in early-stage CLL, watchful waiting doesn’t cause harm compared to starting treatment immediately. University of Rochester Medical Center explains that the goal is to track the disease and intervene if it worsens or symptoms develop.

During watchful waiting, healthcare providers regularly monitor blood counts to identify any changes. They also check for signs of infection, rapid swelling of lymph nodes, liver, or spleen, and symptoms like fatigue, fever, and weight loss. Regular blood tests are essential to assess how counts change over time.

Targeted Therapies: Precision Medicine for CLL

Targeted therapies are medications designed to block specific proteins involved in the growth and survival of cancer cells. These therapies are often recommended as a first-line treatment option due to their potentially milder side effects compared to traditional chemotherapy. NYU Langone Health highlights the increasing utilize of targeted therapies in CLL treatment.

Several targeted therapies are currently used to treat CLL, including:

• acalabrutinib (Calquence)
• ibrutinib (Imbruvica)
• idelalisib (Zydelig)
• pirtobrutinib (Jaypirca)
• venetoclax (Venclexta)
• zanubrutinib (Brukinsa)

Chemotherapy: A Traditional Approach

Chemotherapy involves using powerful medications to kill cancer cells. It can be administered as a pill or intravenously, and doctors may use a single drug or a combination of drugs. Chemotherapy may be considered for individuals who cannot tolerate targeted therapies or have an aggressive form of CLL.

Immunotherapy: Harnessing the Body’s Defense System

Immunotherapy utilizes the body’s own immune system to fight cancer. Two main types of immunotherapy are used in CLL treatment:

• CAR T-cell therapy: This involves removing immune cells from the blood, enhancing them in a lab, and then infusing them back into the body to target and destroy leukemia cells. It’s typically used when targeted therapy isn’t effective and can have significant side effects.
• Monoclonal antibodies: These laboratory-created proteins are infused into the body to attach to cancer cells, attracting immune cells to destroy them. Examples include rituximab (Rituxan) and obinutuzumab (Gazyva).

Stem Cell Transplant: An Intensive Treatment Option

Stem cell transplantation involves using high doses of chemotherapy or radiation to destroy cancerous cells in the bone marrow, followed by the infusion of healthy stem cells – either from the patient (autologous transplant) or a donor (allogeneic transplant) – to rebuild the blood-forming system. This treatment is less common for CLL.

Radiation Therapy and Surgery: Less Common Approaches

Radiation therapy, using X-rays or other energy types to kill cancer cells, may be used to alleviate pain or prepare for a stem cell transplant. Surgery is rarely used to cure CLL, as it often spreads to multiple organs, but may be necessary to remove an enlarged spleen, reducing strain on other organs and improving red blood cell counts.

Leukapheresis: Managing High White Blood Cell Counts

In rare cases, a very high number of CLL cells in the blood can cause circulation problems. Leukapheresis, a procedure that removes white blood cells and leukemia cells from the blood before returning it to the body, can provide temporary relief and allow other treatments to take effect.

Looking Ahead

Treatment for CLL is continually evolving, with ongoing research leading to new and improved therapies. The best course of action for any individual with CLL will be determined by a healthcare professional based on a comprehensive evaluation of their specific situation. Early detection, careful monitoring, and access to innovative treatments offer hope for individuals living with this chronic condition.